Cargando…
TNK2/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability
The challenge of rapid macromolecular synthesis enforces the energy-hungry cancer cell mitochondria to switch their metabolic phenotypes, accomplished by activation of oncogenic tyrosine kinases. Precisely how kinase activity is directly exploited by cancer cell mitochondria to meet high-energy dema...
Autores principales: | Chouhan, Surbhi, Sawant, Mithila, Weimholt, Cody, Luo, Jingqin, Sprung, Robert W., Terrado, Mailyn, Mueller, David M., Earp, H. Shelton, Mahajan, Nupam P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980697/ https://www.ncbi.nlm.nih.gov/pubmed/35895804 http://dx.doi.org/10.1080/15548627.2022.2103961 |
Ejemplares similares
-
ACK1/TNK2 Tyrosine Kinase: Molecular Signaling and Evolving Role in Cancers
por: Mahajan, Kiran, et al.
Publicado: (2014) -
Blockade of ACK1/TNK2 To Squelch the Survival of Prostate Cancer Stem-like Cells
por: Mahajan, Nupam P., et al.
Publicado: (2018) -
Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitor
por: Sawant, Mithila, et al.
Publicado: (2023) -
The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer
por: Wu, Xinyan, et al.
Publicado: (2016) -
Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance
por: Sridaran, Dhivya, et al.
Publicado: (2022)